A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease

Arnold E. Postlethwaite, Kee Wong Weng, Philip Clements, Soumya Chatterjee, Barri J. Fessler, Andrew H. Kang, Joseph Korn, Maureen Mayes, Peter A. Merkel, Jerry A. Molitor, Larry Moreland, Naomi Rothfield, Robert W. Simms, Edwin A. Smith, Robert Spiera, Virginia Steen, Kenneth Warrington, Barbara White, Frederick Wigley, Daniel E. Furst

Research output: Contribution to journal › Article › peer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. Oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease'. Together they form a unique fingerprint.

Medicine & Life Sciences